loading

Perché le azioni Myriad Genetics Inc (MYGN) sono in ribasso?

Abbiamo notato un calo di 6.99% nelle azioni di Myriad Genetics Inc (MYGN) durante la sessione di negoziazione di 2025-06-05. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-09:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.

diagnostics_research DGX
$177.83
price up icon 0.43%
diagnostics_research WAT
$352.41
price down icon 0.70%
diagnostics_research LH
$260.59
price up icon 1.40%
$167.96
price down icon 0.12%
diagnostics_research MTD
$1,184.54
price down icon 0.73%
diagnostics_research IQV
$157.47
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):